Evaluation of the effect of adherence to treatment regimen program on quality of life in atrial fibrillation patients hospitalized in Shahid Chamran Hospital in Isfahan in 2017

Abstract

Background and objective: Atrial fibrillation is the most common cardiac arrhythmia, which is associated with reduced quality of life due to prolonged treatment and its recurrence. One of the key goals in the care of patients with atrial fibrillation is increasing adherence to treatment regimen program and the recommendations provided by the treatment group. Thus, the present study was designed and carried out with the aim of determining the effect of treatment regimen program on quality of life in atrial fibrillation patients hospitalized in Shahid Chamran Hospital in Isfahan in 2017. Methodology: This clinical trial study was conducted on patients with atrial fibrillation arrhythmia in the Cardiac Care Unit (CCU) and Post CCU Unit and Internal Heart Surgery Unit of Shahid Chamran Hospital in Isfahan. A total of 50 people were randomly selected as sample of study and assigned to two groups of test and control. The test group received two 45-minute sessions of adherence and educational booklet and they were followed-up for one month through phone call. The control group also received one session of usual care training individually with regard to the illness. Demographic data and quality of life data were collected through Atrial Fibrillation Effects on Quality of Life (AFEQT) before intervention, and one and three month after the intervention. Data were analyzed by descriptive and inferential statistics. Results: There was no significant difference between two groups in terms of quality of life and demographic information before the intervention. However, significant difference was seen between the two groups in terms of quality of life one month and three months after the intervention. Conclusion: The results suggest the positive effects of adherence to treatment regimen program and follow-up of the patients by experienced nurses on quality of life in these patients one and three months after discharge.